Thursday, 7 November 2024
  
Login

Australia's most trusted
source of pharma news

Thursday, 07 November 2024
News

Merck backs homegrown biotech

Posted 5 November 2024 PM

Merck is getting behind Southern RNA, announcing the mRNA contract development and manufacturing organisation (CDMO) as its first-ever Emerging Biotech Grant Program winner in ANZ.

The German multinational first started the grant program in 2014 in the United States and this year expanded its reach to ANZ, Taiwan and South Korea. Merck also runs the program in Europe and China.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (15)

Access & Reimbursement (1)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (3)

Other (13)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.